CMRA - Comera Life Sciences GAAP EPS of -$1.14 revenue of $0.15M August, 10 2022 05:39 PM Comera Life Sciences Holdings Inc. Comera Life Sciences press release ( NASDAQ: CMRA ): Q2 GAAP EPS of -$1.14. Revenue of $0.15M (+114.3% Y/Y). Comera had $5.0 million in cash, cash equivalents and restricted cash as of June 30, 2022. Shares -1.4% AH. For further details see: Comera Life Sciences GAAP EPS of -$1.14, revenue of $0.15M